Results 261 to 270 of about 60,819 (286)
Some of the next articles are maybe not open access.

Infertility with Testicular Cancer

Urologic Clinics of North America, 2015
Testicular germ cell cancer is one of the most curable cancers. Most patients are treated during their reproductive years, making infertility a significant quality of life issue after successful treatment. This focused review evaluates the factors that contribute to infertility and specific fertility risks with the various testicular cancer treatments.
Kevin A. Ostrowski, Thomas J. Walsh
openaire   +3 more sources

Cryptorchidism and Testicular Cancer

Journal of Urology, 1980
An analysis of 125 patients with a history or clinical evidence of cryptorchidism and testicular germinal tumor treated at our hospital from 1934 to 1975 is presented. Cryptorchidism was corrected ipsilaterally or contralaterally in 83 patients with intrascrotal testis cancer when they were from 4 to 42 years old, either spontaneously (21 patients), by
Robert B. Golbey   +6 more
openaire   +2 more sources

Epidemiology of testicular cancer

BJU International, 2009
Testicular cancer is of interest and importance because its incidence has been increasing in most countries over the past four decades. Although it remains an uncommon malignancy overall accounting for 1–2% of all tumours in men, testicular cancer is the most common malignancy in young men.
Rustom P. Manecksha, John M. Fitzpatrick
openaire   +3 more sources

Testicular Cancer

Acta Oncologica, 1988
Testicular cancer, which predominantly occurs in young men, has become increasingly common; it is presently the most common malignancy in men aged 20-34. Despite a lack of knowledge of aetiology, empirical advances, particularly in the management of patients with advanced disease, have been dramatic.
openaire   +2 more sources

Screening for testicular cancer

Cochrane Database of Systematic Reviews, 2011
Testicular cancer commonly affects men aged between 20 and 35 years. Screening for testicular cancer may reduce both morbidity and mortality, yet the effectiveness of any method is unknown. Equally, screening may also promote treatment procedures that are unwarranted or may adversely affect the health outcomes of the patient with no net benefit ...
Dragan Ilic, Marie Misso
openaire   +3 more sources

Testicular cancer in cryptorchids

Cancer, 1982
One-hundred thirty-seven patients with a history or clinical evidence of cryptorchidism and testicular germinal tumor were treated at our hospital from 1934 to 1976. Cryptorchidism was corrected ipsilaterally or contralaterally in 93 patients with intrascrotal testis cancer when they were from 2 to 42 years old, either spontaneously (24 patients), by ...
Florence C. H. Chu   +4 more
openaire   +3 more sources

HLA and testicular cancer

Nature, 1979
HLA IS involved not only in transplantation, but is also associated with many disease states. This first became evident when the major histocompatibility complex of the mouse (H–2) was shown to play a major part in determining resistance to Gross leukaemia virus1.
P H Lange   +3 more
openaire   +3 more sources

Guidelines on Testicular Cancer

European Urology, 2005
To up-date the 2001 version of the EAU testicular cancer guidelines.A non-structured literature review until January 2005 using the MEDLINE database has been performed. Literature has been classified according to evidence-based medicine levels.Testicular cancer is a highly curable disease.
Peter Albers   +8 more
openaire   +2 more sources

Testicular Cancer and Cryptorchidism

British Journal of Urology, 1992
Summary The records of 273 patients with germ cell tumours of the testis referred between 1970 and July 1991 were reviewed. There were 25 (9%) black, 40 (14%) mixed race and 214 (77%) white patients. Histology showed seminoma in 53% and non‐seminomatous and germ cell tumours in 47% of patients. Maldescent of the testis (MDT) was found in 30 patients–an
R. P. Abratt   +2 more
openaire   +3 more sources

The Management of Testicular Cancer [PDF]

open access: possible, 1983
Testicular neoplasms are rare tumors that account for only about 1% of all cancers occurring in males and have an average annual incidence of about 2.3 per 100,000 males in the English-speaking population [19, 32]. Nevertheless, these tumors have a dramatic impact because they occur predominantly in young men.
openaire   +2 more sources

Home - About - Disclaimer - Privacy